By proceeding, you agree to our Terms of Use and Privacy Policy.
Founded in 2019, Arranta Bio is a visionary contract development and manufacturing organization (CDMO) that partners with companies seeking to develop and manufacture complex biological drugs and innovative therapies.
25-27 January 2022
Welcome to the 6th Microbiome Movement - Drug Development Summit Europe As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel
Event Ended
Virtual
Paid
29-30 March 2022
Dedicated to exploring microbiome research and strategies for commercialisation and product development, we bring together KOLs to present a series of R&D case studies. Topics covered include gut health and disease, advances beyond the gut including
USA
San Diego
12-14 April 2022
Supercharge Your LNP Product Quality to Expedite Novel Treatments to Patients | Embrace Technology Innovations to Optimize LNP Formulation, Stability & Process Control to Achieve Seamless Scale-Up, Compliance & Cost Effectiveness With the global nano
Boston
24-25 May 2022
10thMicrobiome R&D and Business Collaboration Forum: Europe Dedicated to exploring microbiome research and strategies for commercialisation and product development
Netherlands
The Hague
24-26 May 2022
Built with biopharmaceutical industry insights, this in-person conference will delve into novel and emerging RNA therapeutics and vaccines such as self-amplifying mRNA vaccines, circular RNA therapeutics and tRNA-based gene therapies for discovery an
21-23 June 2022
The 7th Microbiome Movement - Drug Development Summit?returns to Boston at a pivotal time. As the microbiome therapeutic space matures, with more indications being pursued and more companies conducting trials, the focus of this event - now in its 7th
26-28 July 2022
The most anticipated event of the mRNA calendar, the mRNA-Based Therapeutics Summit is returning for its second year this July as the comprehensive, industry-leading meeting for mRNA experts; your one-stop-shop for all your mRNA-based vaccine and the
16-17 November 2022
The 7th Annual Microbiome Connect: USA 2022 is dedicated to showcasing the leading drug development platforms applying microbes, microbe modulators and microbial-derived components to prevent or treat human diseases or make medical diagnosis.
Phage therapies have shown promise in compassionate use, but limited success of double blind randomised controlled trials has slowed progression through the clinic.
24-26 January 2023
Welcome to the Largest Gathering for mRNA-Dedicated Professionals in Europe The highly anticipated mRNA-Based Therapeutics Summit Europe is returning to Berlin as the most comprehensive, industry-leading meeting for mRNA experts in Europe. Expect exc
Germany
Berlin
31-02 February 2023
From hypothetical to reality, the first ever approval of a microbiome-based therapy is here and is set to propel the industry forward, expanding across a wide range of diseases.
UK
London
17-19 April 2023
Accelerate Novel Lipid Discovery, Optimized Formulation & Tightened CQAs for Process Development to Achieve Scalability & Regulatory Compliance for Improved Product Quality & Widened Therapeutic Windows.
16-18 May 2023
The 2nd Next Generation RNA Therapeutics Summit is back, and it's the only industry event exclusively dedicated to advancing next generation RNA therapeutics and vaccines. The focus is on developing treatments that are more effective and have fewer o
28-30 June 2023
Join the 8th Microbiome Movement Drug Development Summit, an event that brings together top drug developers and technology enablers to advance the field of microbiome drug development. With a focus on cutting-edge science, preclinical and clinical tr
26-28 July 2023
The most anticipated event of the mRNA calendar year is back with a bang! The mRNA-Based Therapeutics Summit is returning for its 3rd year this July as the one-stop-shop for all your mRNA needs, showcasing exclusive new data from the movers and shake
06-07 September 2023
LSX are known for bringing life science investors together to assess and meet with the most promising up-and-coming biotech companies. When the first mRNA vaccines hit the market in 2020, one of our investors asked us to look at the resurgence of the
18-21 September 2023
Join us at the Cell & Gene Therapy Manufacturing & Commercialization US 2023, the premier event dedicated to revolutionizing the field of cell and gene therapy manufacturing, commercialization, and supply chain strategies. As the leading conference i
Hybrid
19-20 October 2023
The 2023 Microbiome & Probiotics R&D and Business Collaboration Forum comes at an exciting time for the microbiome industry. The recent FDA approvals for Seres Therapeutics and MaaT Pharma (Phase III Clinical Trial), along with Vedanta Biosciences’ s
It is an exciting time for the microbiome industry and recent FDA approvals and successful fundraising point towards the industry’s potential for therapeutic applications. Developments in the Skin space such as partnerships, collaboration, and licens